Your browser doesn't support javascript.
loading
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.
Hollis, Robert L; Thomson, John P; van Baal, Juliette; Ilenkovan, Narthana; Churchman, Michael; van de Vijver, Koen; Dijk, Frederike; Meynert, Alison M; Bartos, Clare; Rye, Tzyvia; Croy, Ian; Diana, Patricia; van Gent, Mignon; Creedon, Helen; Nirsimloo, Rachel; Lok, Christianne; Gourley, Charlie; Herrington, C Simon.
Afiliação
  • Hollis RL; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK. robb.hollis@ed.ac.uk.
  • Thomson JP; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • van Baal J; Department of Gynaecologic Oncology, The Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Ilenkovan N; Department of Pathology, The Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Churchman M; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • van de Vijver K; Cancer Research UK Scotland Centre, Beatson Institute for Cancer Research, Glasgow, UK.
  • Dijk F; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • Meynert AM; Department of Gynaecologic Oncology, The Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Bartos C; Department of Pathology, The Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Rye T; Department of Gynaecologic Oncology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Croy I; Department of Pathology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Diana P; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • van Gent M; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • Creedon H; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • Nirsimloo R; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • Lok C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.
  • Gourley C; Department of Gynaecologic Oncology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Herrington CS; Department of Pathology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Sci Rep ; 13(1): 7681, 2023 05 11.
Article em En | MEDLINE | ID: mdl-37169775
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article